Hi everyone,
After 3 years of keeping the beast in its box, it seems to have escaped. I've been on Prostap (I believe it UK Lupron equivalent) and 50mg Bicalutamide and my nadir (around 0.7 has now doubled over the past 6 months. My current reading is 3.1 (12 wks ago, it was 1.5) So the trend is clear, and I see my onco this afternoon. He previously suggested keeping the injections, but switching to Apalutamide. I wonder though if this is just changing the label of this particualr can that we're kicking down the road? Is it likely to have a significant effect.
I am also in need of a CT scan (though our health service is overwhelmed with cancer diagnostics, following Covid). The last scan (pre-Covid) showed no mets, just the same seminal vesicle involvement I've had for a while. I was initial diagnosed as 3.7 Gleason 3+4. So, in a sense I'm back where I started, albeit 13 yrs of extra quality of life!
I'm tempted to ask him to recommend someone who is doing cutting-edge research as I have deliberately given myself a break from keeping up with developments. It seems unlikely that in the past decade there will not have been some treatment developments. A while back I considered going to Germany for more radiation, as, theoretically I was considered to be 'treatable'.
Am I past that stage now? Should I be looking at systemic options? What other cans are available for kicking?
Your help as ever is greatly appreciated!